Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model

GD2-redirected chimeric antigen receptor (CAR) T lymphocytes represent a promising therapeutic option for immunotherapy of neuroblastoma (NB). However, despite the encouraging therapeutic effects observed in some hematological malignancies, clinical results of CAR T cell immunotherapy in solid tumor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Bocca, Paola, Di Carlo, Emma, Caruana, Ignazio, Emionite, Laura, Cilli, Michele, De Angelis, Biagio, Quintarelli, Concetta, Pezzolo, Annalisa, Raffaghello, Lizzia, Morandi, Fabio, Locatelli, Franco, Pistoia, Vito, Prigione, Ignazia
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5739560/
https://ncbi.nlm.nih.gov/pubmed/29296542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1378843
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados